FRASYCE

Serial Number 90009730
606

Registration Progress

Application Filed
Jun 18, 2020
Under Examination
Jun 22, 2021
Approved for Publication
Apr 27, 2021
Published for Opposition
Apr 27, 2021
Registered

Trademark Image

FRASYCE

Basic Information

Serial Number
90009730
Filing Date
June 18, 2020
Published for Opposition
April 27, 2021
Abandonment Date
July 24, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 24, 2023
Classes
005

Rights Holder

ImmunoGen, Inc.

03
Address
830 Winter Street
Waltham, MA 02451

Ownership History

ImmunoGen, Inc.

Original Applicant
03
Waltham, MA

ImmunoGen, Inc.

Owner at Publication
03
Waltham, MA

Legal Representation

Attorney
Nicole Kinsley, Esq.

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Jul 24, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 24, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 30, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 30, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 30, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 30, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Dec 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 9, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 9, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 9, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 14, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 14, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 15, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 13, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 13, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 13, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 22, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 27, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 27, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 7, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 23, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 19, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 19, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 19, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 12, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 21, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 21, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 21, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 21, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 16, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 22, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005